Approvals & regulatory · first seen yesterday, updated yesterday
Grail’s Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval
The FDA is expected to make its final ruling on Galleri’s premarket approval in the coming months.
Summary from WSJ - Health.